Results 31 to 40 of about 75,592 (343)
Context Serum 17-hydroxyprogesterone (17OHP) and androstenedione (A4) are the conventional biomarkers used to assess disease control in patients with 21-hydroxylase deficiency (21OHD).
S. Jha +5 more
semanticscholar +1 more source
PURPOSE Defects in both CYP21A2 and TNXB genes can cause congenital adrenal hyperplasia combined with hypermobility type Ehlers-Danlos syndrome, which has recently been named CAH-X syndrome.
Yinjie Gao +6 more
semanticscholar +1 more source
Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care [PDF]
Steroid 21-hydroxylase deficiency is the most prevalent form of congenital adrenal hyperplasia (CAH), accounting for approximately 95% of cases. With the advent of newborn screening and hormone replacement therapy, most children with CAH survive into ...
Jin-Ho Choi, Han-Wook Yoo
doaj +1 more source
Despite numerous studies in the field of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency, some clinical variability of the presentation and discrepancies in the genotype/phenotype correlation are still unexplained. Some, but not all,
M. Kocova, V. Anastasovska, H. Falhammar
semanticscholar +1 more source
Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
Congenital adrenal hyperplasia includes autosomal recessive conditions that affect the adrenal cortex steroidogenic enzymes (cholesterol side-chain cleavage enzyme; 3β-hydroxysteroid dehydrogenase; 17α-hydroxylase/17,20 lyase; P450 oxidoreductase; 21 ...
Antonio Balsamo +7 more
doaj +1 more source
The positive predictive value of newborn screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency was
Mark R de Hora +5 more
semanticscholar +1 more source
Compliance Issues in Managing 21 Hydroxylase Deficiency and their Short/Long-Term Consequences
Objective: To report a case of untreated classic 21 hydroxylase (OH) deficiency congenital adrenal hyperplasia (CAH) in a transgender patient resulting in pulmonary embolisms (PEs) and bilateral adrenal masses.
Jack Lin +3 more
doaj +1 more source
Obesity in 21-hydroxylase deficient patients [PDF]
To evaluate the natural history and timing of adiposity rebound (nadir of body mass index (BMI)) in children with congenital adrenal hyperplasia 21-hydroxylase deficiency (CYP21).A retrospective mixed longitudinal study.Height and changes in body composition (BMI; weight (kg)/height2 (m)), triceps and subscapular skinfolds) were analysed in 22 (14 ...
R E, Cornean, P C, Hindmarsh, C G, Brook
openaire +2 more sources
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disorder of the adrenal cortex characterized by impairment of cortisol biosynthesis (with possible impairment of aldosterone biosynthesis) and ...
Boris M. Shifman +4 more
doaj +1 more source
ObjectiveTo analyze the mutational spectrum, clinical characteristics, genotype–phenotype correlations, testicular adrenal rests tumor prevalence, and role of neonatal screening in congenital adrenal hyperplasia (CAH) patients from Slovakia and Slovenia ...
Robert Saho +21 more
doaj +1 more source

